Related Experiment Video
Updated: Feb 14, 2026

The Intra-Aortic Balloon Pump
Published on: February 5, 2021
Magic Touch®: preliminary clinical evidence with a novel sirolimus drug coated balloon
Bernardo Cortese1,2, Gaetano Di Palma3,4, Roberto Latini3
1ASST Fatebenefratelli-Sacco, Milan, Italy - bcortese@gmail.com.
Abstract:
Drug-coated balloons (DCB) have been developed in recent years to overcome some of the drug-eluting stents limitations. There is an established indication for the use of DCB in the treatment of in-stent restenosis and they are also variably used in various setting, in particular small coronary vessels and bifurcations. Until 2016, all DCBs available in Europe eluted paclitaxel, a highly lipophilic drug with narrow therapeutic window. In April 2016 a new sirolimus-coated balloon (Magic Touch®, Envision Scientific PVT, Bhatpore, India) obtained the CE Mark. This device shares a new-generation delivery system and is able to release in a few seconds an effective dosage of sirolimus.
More Related Videos
Related Concept Videos
The Evidence for Evolution
Magical Thinking
Responses to Gravity and Touch
Clinically Relevant Drug Product Specifications: Methods of Establishment
Pinching-off of Coated Vesicles
Clathrin Coated Vesicles

